Costunolide Induces G1/S Phase Arrest and Activates Mitochondrial-mediated Apoptotic Pathways in SK-MES 1 Human Lung Squamous Carcinoma Cells
Overview
Affiliations
Despite the availability of several therapeutic options, a safer and more effective modality strategy is required for the treatment of lung cancer. Costunolide, a sesquiterpene lactone which isolated from the Saussurea lappa, has potent anticancer properties. In the present study, the effects of costunolide on cell viability, the cell cycle and apoptosis in SK-MES-1 human lung squamous carcinoma cells were investigated. Costunolide induced morphological changes and inhibited growth of SK-MES-1 cells growth. Flow cytometric analysis data demonstrated that costunolide significantly induced apoptosis of SK-MES-1 cells and induced cell cycle arrest at G1/S phase in a dose-dependent manner. Through upregulation in the expression of p53 and Bax, and downregulation in the expression of Bcl-2 and activation of caspase-3, costunolide-induced apoptosis was confirmed by western blot analysis. In addition, the significant loss of mitochondrial membrane potential indicated that costunolide may induce apoptosis via the mitochondria-dependent pathway in SK-MES-1 cells. These results highlight the potential effects of costunolide as an anti-cancer agent in a human lung squamous carcinoma cell line.
Current and potential future biological uses of (Falc.) Lipsch: A comprehensive review.
Elnour A, Abdurahman N Heliyon. 2024; 10(18):e37790.
PMID: 39323795 PMC: 11422592. DOI: 10.1016/j.heliyon.2024.e37790.
Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis.
Hsu C, Rajabi S, Hamzeloo-Moghadam M, Kumar A, Maresca M, Ghildiyal P Front Pharmacol. 2024; 15:1371002.
PMID: 38529189 PMC: 10961375. DOI: 10.3389/fphar.2024.1371002.
Liu X, Li H, Wang S, Zhang J, Liu D Chin Herb Med. 2022; 13(2):167-176.
PMID: 36117502 PMC: 9476744. DOI: 10.1016/j.chmed.2020.11.005.
Awan Z, Alghamdi S, Alhakamy N, Okbazghi S, Alfaleh M, Badr-Eldin S Drug Deliv. 2022; 29(1):1536-1548.
PMID: 35612292 PMC: 9154778. DOI: 10.1080/10717544.2022.2072412.
Alhakamy N, Badr-Eldin S, Ahmed O, Aldawsari H, Okbazghi S, Alfaleh M Pharmaceutics. 2022; 14(2).
PMID: 35213960 PMC: 8880633. DOI: 10.3390/pharmaceutics14020227.